Skip to main content

Qigong Beneficial for Veterans With Chronic Low Back Pain

Medically reviewed by Carmen Pope, BPharm. Last updated on Feb 3, 2025.

By Lori Solomon HealthDay Reporter

MONDAY, Feb. 3, 2025 -- The traditional Chinese practice of qigong can effectively alleviate chronic low back pain (CLBP), according to a study recently published in Pain Management Nursing.

Cheryl A. Krause-Parello, Ph.D., R.N., from Florida Atlantic University in Boca Raton, and colleagues examined the preliminary efficacy of an eight-week qigong intervention for managing biopsychosocial outcomes in veterans with CLBP. The analysis included 31 participants who were randomly assigned to qigong or a wait-list control.

The researchers found that participants in the qigong group showed greater improvement in pain intensity, pain interference, pain-related disability, and sleep disturbance. There was a statistically significant relationship between biological outcomes (proinflammatory cytokines) and psychosocial outcomes (e.g., tumor necrosis factor and physical function, and interleukin 8 and both pain-related disability and symptoms of posttraumatic stress disorder).

"Stretching, loosening, strengthening, and balancing techniques of qigong may release back tension, ease pain, and improve flexibility and alignment," Krause-Parello said in a statement. "Qigong practice can strengthen the musculoskeletal system and improve joint flexibility, motor function, and movement coordination. It can activate postural improvements and decrease pain. Importantly, it can improve physical conditions and psychosocial function such as depression and social isolation in veterans with chronic back pain."

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted February 2025

Read this next

AACR: Incidence-Based Mortality Dropping for Young Women With Breast Cancer

TUESDAY, April 29, 2025 -- Incidence-based mortality (IBM) declined from 2010 to 2020 among women aged 20 to 49 years diagnosed with breast cancer, according to a study presented...

AACR: Nonsurgical Treatment Feasible for Mismatch Repair-Deficient Tumors

TUESDAY, April 29, 2025 -- A neoadjuvant programmed cell death 1 (PD-1) blockade enables nonoperative management among patients with early-stage mismatch repair-deficient (dMMR)...

Outcomes With Immune Checkpoint Inhibitors Similar for Older, Younger Patients

TUESDAY, April 29, 2025 -- Patients with cancer aged 65 years and older receiving immune checkpoint inhibitors (ICIs) derive similar clinical outcomes as younger patients...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.